TITLE

Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results

AUTHOR(S)
Schaling, D F; van der Pol, J P; Jager, M J; van Kroonenburgh, M J; Oosterhuis, J A; Ruiter, D J
PUB. DATE
September 1990
SOURCE
British Journal of Ophthalmology;Sep1990, Vol. 74 Issue 9, p538
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66122603

 

Related Articles

  • COMS finds little added benefit for radiation before surgery. Samiy, Nasrollah; Straatsma, Bradley R. // Ophthalmology Times; 

    Focuses on the benefits of pre-enucleation radiation therapy for patients with choroidal melanoma. Results of the Collaborative Ocular Melanoma Study; Clinical diagnosis of choroidal melanoma.

  • Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients? Schirosi, Laura; Strippoli, Sabino; Gaudio, Francesca; Graziano, Giusi; Popescu, Ondina; Guida, Michele; Simone, Giovanni; Mangia, Anita // BMC Cancer;11/18/2016, Vol. 16, p905 

    Background: In clinical practice the gold standard method to assess BRAF status in patients with metastatic melanoma is based on molecular assays. Recently, a mutation-specific monoclonal antibody (VE1), which detects the BRAF V600E mutated protein, has been developed. With this...

  • Preliminary Results on Clinico-pathological and Immunohistochemical Features of Malignant Melanomas. Ciortea, Carmen Diana; Gurzu, Simona; Zdrob, Simona Maria; Jung, I. // Acta Medica Marisiensis;2013, Vol. 59 Issue 4, p201 

    Objective: To perform a retrospective clinico-pathological and immunohistochemical analysis of malignant melanomas. Methods: One-hundred sixty consecutive cases diagnosed in the Department of Pathology of the County Emergency Clinical Hospital of Tîrgu Mureş, Romania, between January 2000...

  • Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. Massi, Daniela; Simi, Lisa; Sensi, Elisa; Baroni, Gianna; Xue, Gongda; Scatena, Cristian; Caldarella, Adele; Pinzani, Pamela; Fontanini, Gabriella; Carobbio, Alessandra; Urso, Carmelo; Mandalà, Mario // Modern Pathology;Apr2015, Vol. 28 Issue 4, p487 

    No abstract available.

  • Melanoma vaccines: trials and tribulations. Dillman, Robert O. // Vaccine: Development & Therapy;2013, Vol. 3, p57 

    Metastatic melanoma has been a target of immunotherapy for more than 4 decades. Three immunotherapeutics have received regulatory approval for treating melanoma: interferon- alpha, interleukin-2, and ipilimumab. The antitumor mechanisms of these products depend on enhancing existing immune...

  • Identification of Monoclonal Anti-HMW-MAA Antibody Linear Peptide Epitope by Proteomic Database Mining. Mittelman, Abraham; Tiwari, Raj; Lucchese, Guglielmo; Willers, Jörg; Dummer, Reinhard; Kanduc, Darja // Journal of Investigative Dermatology;Oct2004, Vol. 123 Issue 4, p670 

    An efficient strategy is presented for the identification of antigenic sequences in the context of given MHC molecules of interest. The proteomic analysis of the antigenic peptide repertoire is described and demonstrated by using high-molecular weight melanoma-associated antigen. The...

  • The expression of human high molecular weight melanomaassociated antigen in acral lentiginous melanoma. Nishi, Hazuki; Inoue, Yuji; Kageshita, Toshiro; Takata, Minoru; Ihn, Hironobu // BioScience Trends;Apr2010, Vol. 4 Issue 2, p86 

    The high molecular weight melanoma-associated antigen (HMW-MAA) is a membrane-bound chondroitin sulphate proteoglycan that is highly expressed on the surface of melanoma cells. It represents an attractive target for immunotherapy of malignant melanoma. Previously, it was reported that HMW-MAA...

  • A Newly Developed Mouse Monoclonal SOX10 Antibody Is a Highly Sensitive and Specific Marker for Malignant Melanoma, Including Spindle Cell and Desmoplastic Melanomas. Tacha, David; Weimin Qi; Seong Ra; Bremer, Ryan; Yu, Charlie; Chu, Joseph; Hoang, Laura; Robbins, Bruce // Archives of Pathology & Laboratory Medicine;Apr2015, Vol. 139 Issue 4, p530 

    Context .- Recent immunohistochemical studies have demonstrated Sry-related HMG-Box gene 10 (SOX10) expression in malignant melanomas, malignant peripheral nerve sheath tumors, a subset of breast carcinomas, and gliomas. SOX10 has shown important clinical utility in its ability to detect...

  • Nuclear medicine. Royal, Henry D.; Siegel, Barry A. // JAMA: Journal of the American Medical Association;06/18/97, Vol. 277 Issue 23, p1875 

    Reports on advances in nuclear medicine. Expanding role of stress myocardial perfusion imaging; Radiolabeled monoclonal antibodies for diagnostic radioimmunoscintigraphy in cancer patients; Handheld radiation detectors for intraoperative detection of sentinal lymph nodes and tumors.

  • Avemar Outshines New Cancer 'Breakthrough' Drug. Traub, Michael // Townsend Letter;Oct2010, Issue 327, p72 

    The article looks at the results of the phase III clinical trial of the experimental monoclonal antibody ipilimumab developed to manage metastatic melanoma, presented at the annual meeting of the American Society of Clinical Oncology (ASCO). Findings suggested that about 45.6% of patients taking...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics